The DGKζ shRNA led to worsened systolic and diastolic dysfunction, as evidenced by a reduction in LVEF, LVFS, and e'/a', but an increase in the thickness of the left ventricular wall and the ratio of E/A 8 weeks after TAC. The gene discussed is DGKZ; the disease is persistent truncus arteriosus.